Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Big Pharma
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Homecoming 2026 promises to draw a full house
The theme of this year’s celebration is “The Louie of Hearts,” and the schedule of events includes familiar favorites and new traditions.
MORE IN Big Pharma
LATEST NEWS
- Homecoming 2026 promises to draw a full house
- Foreign Policy magazine taps Susan Brownell’s expertise to discuss China’s growing prominence in Winter Olympic Games
- Guest lecturer Steven Shapiro gives UMSL entrepreneurship students a peek into the hotel industry
- Eye on UMSL: Making connections
- Faculty and staff find inspiration while giving to support students
- UMSL Tritons weekly rewind
- English alum Marty Ambrose builds on a lifelong love of poetry in the classroom and in her historical mysteries
- Ask an expert: Associate Professor Temidayo Akenroye explore issues of sustainability in supply chains in three new books
- Eye on UMSL: Global engagement
- UMSL partnering with FOCUS St. Louis to host second annual Start With Leadership Conference
